课题基金 / 基金详情

IMMUNOGENETICS OF HYBRID RESISTANCE

IMMUNOGENETICS OF HYBRID RESISTANCE
混合抗性的免疫遗传学
批准号:
3174576
负责人:
Michael Bennett
金额:
$7.59万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-03-01 至 1987-02-28

项目摘要

项目成果

Michael Bennett的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hybrid resistance is the prevention of proliferation of grafts of H-2 homozygous normal or neoplastic hemopoietic cells by F1 hybrid mice heterozygous at H-2. This observation goes against the laws of transplantation genetics, which state that histocompatibility antigens are inherited codominantly. The determinants for the major hybrid or hemopoietic histocompatibility (Hh) antigens map at H-2D. The aims here are to determine if genes in the trans or cis configuration with Hh regulate expression so as to determine immunogenicity of donor cells and presence or absence of hybrid resistance in F1 hybrid hosts. The possibility of allogeneic inhibition, i.e., recognition of host alloantigens by the donor cells to initiate the response, will be investigated. Finally, the mechanism of tolerance induction to Hh antigens will be explored. The potential importance of this work relates to autoimmunity and tumor immune surveillance, since the parent and the F1 hybrid share the structural gene for the same Hh antigen. (SR)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-canonical mechanisms of excitotoxicity
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
  • 批准号:
    6376235
  • 项目类别:
  • 资助金额:
    $21.06万
  • 财政年份:
    2000
  • 负责人:
    Michael Bennett
  • 依托单位:
PATHOLOGY UTSWMC
  • 批准号:
    6340695
  • 项目类别:
  • 资助金额:
    $12.43万
  • 财政年份:
    2000
  • 负责人:
    Michael Bennett
  • 依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
  • 批准号:
    6633105
  • 项目类别:
  • 资助金额:
    $21.06万
  • 财政年份:
    2000
  • 负责人:
    Michael Bennett
  • 依托单位:
海外基金